Skip to main content

Table 2 Risk factors for enterococcal infection

From: Clinical characteristics and risk factors of enterococcal infections in Nagasaki, Japan: a retrospective study

 

Enterococcal infections

Enterococcus faecalis infections

Enterococcus faecium infections

Infections

Controls

Univariate

Multivariate

Infections

Controls

Univariate

Multivariate

Infections

Controls

Univariate

Multivariate

n = 182

n = 358

p value

Adjusted OR (95 % CI)

p value

n = 144

n = 275

p value

Adjusted OR (95 % CI)

p value

n = 38

n = 83

p value

Adjusted OR (95 % CI)

p value

Age, years, mean (SD)

64.6 (18.2)

61.6(22.4)

0.458

-

-

65.0 (19.3)

60.7 (23.0)

0.187

-

-

64.8(13.5)

64.7 (20.1)

0.351

-

-

Sex (male), n (%)

114 (62.6)

183 (51.1)

0.011

1.504 (1.032-2.190)

0.033

89 (61.8)

142 (51.6)

0.047

-

-

25 (65.8)

41 (49.4)

0.094

-

-

Comorbidities, n (%)

               

Diabetes mellitus

38 (20.9)

80 (22.3)

0.697

-

-

31 (21.5)

63 (22.9)

0.748

-

-

7 (18.4)

17 (20.5)

0.793

-

-

Cancer and hematologic malignancy

96 (52.7)

171 (47.8)

0.274

-

-

77 (53.5)

131 (47.6)

0.257

-

-

19 (50.0)

40 (48.2)

0.854

-

-

Chronic kidney disease

52 (28.6)

109 (30.4)

0.653

-

-

39 (27.0)

84 (30.5)

0.46

-

-

13 (34.2)

25 (30.1)

0.654

-

-

Structural abnormality of the urinary tract

21 (11.5)

22 (6.1)

0.029

2.086 (1.088–4.000)

0.027

20 (13.8)

17 (6.2)

0.008

2.634 (1.294–5.362)

0.008

1 (2.6)

5 (6.0)

0.427

-

-

Hemodialysis

12 (6.6)

33 (9.2)

0.297

-

-

10 (6.9)

20 (7.3)

0.902

-

-

2 (5.3)

13 (15.6)

0.109

-

-

Therapy for comorbidities, n (%)

               

Abdominal surgery

90 (49.5)

102 (28.5)

0

2.233 (1.529–3.261)

0

68 (47.2)

72 (26.2)

0

2.263 (1.464–3.498)

0

22 (57.9)

30 (36.1)

0.025

-

-

Steroids

42 (23.1)

75 (20.9)

0.571

-

-

23 (16.0)

47 (17.1)

0.771

-

-

19 (50.0)

28 (33.7)

0.09

-

-

Immunosuppressive agents

30 (16.5)

41 (11.5)

0.102

-

-

17 (11.8)

29 (10.5)

0.696

-

-

13 (34.2)

12 (14.5)

0.013

3.837 (1.397–10.541)

0.009

Chemotherapy

30 (16.5)

62 (17.3)

0.807

-

-

23 (16.0)

47 (17.1)

0.771

-

-

7 (18.4)

15 (18.1)

0.963

-

-

Urinary catheterization, n (%)

75 (41.2)

145 (40.5)

0.875

-

-

57 (39.6)

103 (37.5)

0.671

-

-

18 (47.4)

42 (50.6)

0.742

-

-

Using in situ device, n (%)

120 (65.9)

190 (53.1)

0.004

-

-

86 (59.7)

132 (48.0)

0.023

-

-

34 (89.5)

58 (69.9)

0.02

3.807 (1.180-12.276)

0.025

Hemoglobin (g/dL), mean (SD)

9.89 (1.97)

10.2 (2.0)

0.093

-

-

10.0 (2.0)

10.4 (2.1)

0.17

-

-

9.37 (1.96)

9.63 (1.48)

0.143

-

-

Albumin (g/dL), mean (SD)

2.86 (0.63)

3.06 (0.87)

0.01

0.731 (0.555-0.963)

0.026

2.86 (0.63)

3.13 (0.93)

0.002

0.668 (0.490-0.911)

0.011

2.88 (0.63)

2.85 (0.55)

0.823

-

-

In-hospital mortality (%)

8.2

8.9

0.786

-

-

9

7.3

0.527

-

-

5.3

14.5

0.144

-

-

Total hospital stay (days), mean (±SD)

80.9 (95.0)

74.0 (110)

0.053

-

-

77.5 (101)

70.8 (95.0)

0.223

-

-

93.8 (68.3)

86.8 (149)

0.04

-

-

 

Hosmer–Lemeshow: p = 0.571

Hosmer–Lemeshow: p = 0.825.

Hosmer–Lemeshow: p = 0.677.